CATALOGO DEI PRODOTTI DELLA RICERCA

CINGARLINI, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.720
NA - Nord America 2.568
AS - Asia 1.390
SA - Sud America 26
AF - Africa 10
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.546
GB - Regno Unito 922
CN - Cina 915
IT - Italia 379
SE - Svezia 312
SG - Singapore 300
IE - Irlanda 263
DE - Germania 196
RU - Federazione Russa 192
FR - Francia 190
FI - Finlandia 140
UA - Ucraina 34
TR - Turchia 33
BE - Belgio 29
VN - Vietnam 24
KR - Corea 23
JP - Giappone 20
NL - Olanda 17
HK - Hong Kong 16
CA - Canada 15
IR - Iran 15
BR - Brasile 12
IN - India 11
ID - Indonesia 8
LV - Lettonia 8
AT - Austria 6
ES - Italia 6
MX - Messico 6
CH - Svizzera 5
CL - Cile 5
PH - Filippine 5
AU - Australia 4
AZ - Azerbaigian 4
TG - Togo 4
AR - Argentina 3
MA - Marocco 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CM - Camerun 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
MK - Macedonia 2
NO - Norvegia 2
PE - Perù 2
PL - Polonia 2
SA - Arabia Saudita 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.721
Salva come PNG Salva come JPEG
Città #
Southend 866
Chandler 614
Singapore 260
Dublin 254
Jacksonville 244
Ann Arbor 214
Woodbridge 204
Beijing 174
Ashburn 155
Verona 114
Houston 86
New York 86
Jinan 76
Lawrence 76
Princeton 76
Wilmington 72
Shenyang 70
Helsinki 59
Nanjing 53
Tianjin 41
Hebei 40
Haikou 34
Redmond 32
Changsha 31
Zhengzhou 31
Brussels 29
Milan 28
Guangzhou 27
Sindelfingen 24
Nanchang 23
Seattle 23
Taiyuan 23
Bologna 22
Hangzhou 22
Ningbo 20
Taizhou 20
Lancaster 19
Redwood City 19
Seoul 18
Jiaxing 15
Santa Clara 15
Hong Kong 14
Tokyo 14
Kent 13
Boardman 12
Dong Ket 12
Washington 11
Fuzhou 10
Los Angeles 10
Dallas 9
Norwalk 9
Shanghai 9
Toronto 9
Dearborn 8
Falkenstein 7
Amsterdam 6
Genova 6
Jakarta 6
Leawood 6
Moscow 6
Rome 6
San Francisco 6
Chicago 5
Dongguan 5
Düsseldorf 5
Florence 5
Foresto 5
Hamburg 5
Kyoto 5
São Paulo 5
Baku 4
Cagliari 4
Fairfield 4
Grezzana 4
Lanzhou 4
Lappeenranta 4
Lomé 4
Riese Pio X 4
Riga 4
Trento 4
Boydton 3
Bronx 3
Clearwater 3
Detroit 3
Genazzano 3
Legnaro 3
London 3
Pisa 3
San Diego 3
San Mateo 3
Santa Marinella 3
Sejong 3
Shenzhen 3
Tappahannock 3
Tashkent 3
Telgate 3
Windsor 3
Zanjan 3
Brno 2
Buenos Aires 2
Totale 4.636
Salva come PNG Salva come JPEG
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 174
Anti PSMA immunotoxins activity against prostate cancer cell lines. 128
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 122
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 121
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 120
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 115
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 112
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 112
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 111
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 110
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 110
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 109
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 109
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 108
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 108
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 107
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 107
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 105
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 105
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 105
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 105
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 104
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 103
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 103
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 103
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 103
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 102
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 102
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 101
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 100
ESGAR 2016 Book of Abstracts 96
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 94
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 94
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 93
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 93
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 92
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 92
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 91
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 90
Preclinical studies of a new anti-psma (prostate specific membrane antigen) antibody for diagnosis and immunotargeting 89
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 88
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 87
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 83
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 83
The development of PARP as a successful target for cancer therapy 83
Streptozotocin/5-Fluorouracil (STZ/5FU) Chemotherapy in G1-G2 Pancreatic Neuroendocrine Tumors (pNETs): Single Institution Experience 82
Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology 80
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 80
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 79
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models 77
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 77
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 76
Profiling mTOR pathway in neuroendocrine tumors 75
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 75
Imaging presentation of pancreatic neuroendocrine neoplasms 74
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 74
Prognostic Stratification and Therapeutic Response Assessment in Liver and Pancreatic Tumors: the New Imaging 72
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 72
Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors: Why Not? 71
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 71
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 69
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 68
Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging 67
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 67
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome 64
Normal Tissue Perfusion Changes During Everolimus Treatment: Preliminary Results from a Functional Vascular Study 62
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 62
Is Laparoscopic CME Right Hemicolectomy an Optimal Indication for NET of the Right Colon and Terminal Ileum? 58
Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios 56
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 55
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 54
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 53
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 53
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 48
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 42
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 37
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 35
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups 33
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant? 31
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 23
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 11
Totale 6.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.106
article - articoli 16.839
book - libri 0
conference - conferenze 7.171
curatela - curatele 0
other - altro 288
patent - brevetti 562
selected - selezionate 0
volume - volumi 246
Totale 50.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020354 0 0 0 0 0 0 79 32 49 59 52 83
2020/2021644 79 101 44 89 82 50 14 37 41 17 62 28
2021/2022786 65 256 18 70 37 17 14 44 23 18 53 171
2022/20231.625 96 211 148 287 108 429 38 88 173 9 25 13
2023/2024835 29 66 75 82 90 166 25 50 9 65 144 34
2024/2025772 104 112 108 273 99 76 0 0 0 0 0 0
Totale 6.855